HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Wang, X. Articles by Cutting, G. R. Search for Related Content PubMed PubMed Citation Articles by Wang, X. Articles by Cutting, G. R. Related Collections Molecular Diagnostics and Genetics

Development and Evaluation of a PCR-based, Line Probe Assay for the Detection of 58 Alleles in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene

¹ Johns Hopkins University School of Medicine, Baltimore, MD 21287;
² Roche Molecular Systems, Alameda, CA 94501

^aaddress correspondence to this author at: Johns Hopkins University School of Medicine, CMSC 9-120, Baltimore, MD 21287; fax 410-955-0484, e-mail gcutting@jhmi.edu

The first 20% of the full text of this article appears below.

Cystic fibrosis (CF) is the most common life-limiting recessive genetic disorder in Caucasians, with an incidence of 1 in 3200 newborns (1). The disease is less common in Hispanic Americans (1 in 9200), African Americans (1 in 15 000), and Asian Americans (1 in 31 000) (2). The diagnosis of CF requires the presence of one or more characteristic phenotypic features, a history of CF in a sibling, or a positive newborn screening test result plus laboratory evidence of cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction (3). Although sweat chloride testing continues to be the laboratory test of choice, DNA testing is growing in popularity, especially in situations where sweat testing is unavailable or ambiguous. In 1999, 9.1% of patients attending CF centers in the United States had DNA analysis as a confirmatory diagnostic test (4). Furthermore, DNA testing is the only method available that can readily identify the carriers of CF mutations and, therefore, is the only tool for CF carrier screening.

The gene responsible for CF, the CFTR gene, was identified by positional cloning (5)(6). Nearly 1000 putative disease-associated mutations have been reported in CFTR, but only a few dozen have a frequency >0.1% in the general population (1)(7). Thus, efficient and accurate population screening for CF requires an assay that can simultaneously detect the mutated and wild-type sequences of 30 CF alleles. We have developed the Research Prototype Cystic Fibrosis Assay-31, which uses multiplex PCR (8)(9) and colorimetric detection with sequence-specific oligonucleotide probes immobilized in a linear array on nylon membranes (10. . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				L. L. Vanscoy, S. M. Blackman, J. M. Collaco, A. Bowers, T. Lai, K. Naughton, M. Algire, R. McWilliams, S. Beck, J. Hoover-Fong, et al. Heritability of Lung Disease Severity in Cystic Fibrosis Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 1036 - 1043. [Abstract] [Full Text] [PDF]

				K. Buranawuti, M. P Boyle, S. Cheng, L. L Steiner, K. McDougal, M D. Fallin, C. Merlo, P. L Zeitlin, B. J Rosenstein, P. J Mogayzel Jr, et al. Variants in mannose-binding lectin and tumour necrosis factor {alpha} affect survival in cystic fibrosis J. Med. Genet., March 1, 2007; 44(3): 209 - 214. [Abstract] [Full Text] [PDF]

				X. Wang, J. Kim, R. McWilliams, and G. R. Cutting Increased Prevalence of Chronic Rhinosinusitis in Carriers of a Cystic Fibrosis Mutation Arch Otolaryngol Head Neck Surg, March 1, 2005; 131(3): 237 - 240. [Abstract] [Full Text] [PDF]